Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Procedure Conducted by Techniques & End-User The CAGR for the Breast lesion localization market is 11.68%, $1.02 billion in 2022 with a value of USD 1.14 bn in 2023 and expected to reach USD 2.47 billion by 2030. Breast lesion localization refers to identifying and localizing abnormal tissue or lesions in the breast, which may indicate cancer or other diseases. The accurate localization of breast lesions is critical for effective diagnosis and treatment planning, and several methods are available for achieving this goal. The breast lesion localization methods market encompasses a range of devices, techniques, and technologies used to identify, locate, and mark breast lesions for further evaluation. The most common breast lesion localization methods include mammography, ultrasound, MRI, and biopsy. Mammography is the most standard method for breast lesion localization, involving X-rays to capture breast tissue images. As per a report by the Centers for Disease Control and Prevention (CDC), in 2020, 63.9% of women aged 50-74 had a mammogram within two years in the United States. Ultrasound uses sound waves to produce breast images, while MRI uses radio waves and magnetic fields to create detailed breast tissue images. A biopsy involves the removal of a sample of tissue from the breast for further analysis. In recent years, new technologies and techniques have emerged to improve the accuracy and efficiency of breast lesion localization. These include methods such as stereotactic biopsy, which uses a computer to guide a needle to the precise location of the lesion, and wire localization, which involves the insertion of a thin wire into the breast to guide the surgeon to the location of the lesion during surgery. The breast lesion localization methods market is driven by factors such as the rising incidence of breast cancer worldwide, increasing awareness and screening programs, and technological advancements in breast imaging and biopsy techniques. Key players in the market include medical device companies such as Hologic Inc., GE Healthcare, Siemens Healthineers, and Koninklijke Philips N.V. Overall, the breast lesion localization methods market is estimated to continue growing in the coming years as demand for accurate and efficient breast cancer diagnosis and treatment continues to increase. Several key drivers are contributing to the growth of the breast lesion localization methods market: Growing Geriatric Population and Increase in Breast Cancer Diagnosis: According to WHO, Breast cancer is the most commonly diagnosed cancer among women worldwide, with an estimated 2.3 million new cases diagnosed each year. As the incidence of breast cancer continues to rise, there is a growing need for accurate and efficient methods for lesion localization to enable earlier detection and more effective treatment. Breast cancer is more common among older women, and as the global population ages, the demand for breast lesion localization methods is expected to increase. Rising Awareness and Screening Programs: The importance of regular breast cancer screening and early detection is increasingly recognized, leading to a growing demand for breast lesion localization methods. As per the National Cancer Institute (NCI), the most prevalent form of cancer in American women is breast cancer, with an estimated 281,550 new cases expected to be diagnosed in 2023. Early detection through breast cancer screening, including mammography and breast lesion localization, can improve outcomes and reduce mortality rates. Governments and healthcare organizations worldwide are implementing breast cancer screening programs, further driving the market's growth. Technological Advancements: The breast lesion localization methods market is benefiting from advances in imaging and biopsy techniques, enabling more accurate and efficient detection and localization of breast lesions. A study by Accenture found that Technology has the potential to create $150 billion in annual savings for the United States healthcare economy by 2026. These advances include improvements in mammography, ultrasound, and MRI technologies and the development of new techniques such as stereotactic biopsy and wire localization. Increasing Healthcare Expenditure: Healthcare expenditure is increasing worldwide, providing more resources for developing and adopting new breast lesion localization technologies and techniques. According to the US Department of the Centers for Medicare & Medicaid Services, US healthcare spending grew 2.7 percent in 2021, reaching $4.3 trillion or $12,914 per person. This is expected to further fuel the market's growth in the coming years. Restraints: High cost of breast lesion localization procedures: One of the major restraints in the breast lesion localization methods market is the high cost of the procedures involved. These procedures, which include mammography, MRI, and biopsy, can be costly and may not be covered by insurance in all cases. This can limit the accessibility of breast lesion localization treatment for some patients, particularly in developing countries. Risk of complications and side effects: Breast lesion localization procedures carry a risk of complications and side effects, which can be a significant concern for patients. For example, biopsy procedures can cause pain, bleeding, and infection, while mammography and MRI can cause discomfort and anxiety. The risk of complications and side effects can discourage some patients from seeking breast lesion localization procedures or may lead to a preference for less invasive methods. Limited availability and adoption of new technologies and Limited accuracy of current technologies: While there are many advances in breast lesion localization technologies and techniques, not all of these technologies are widely available or adopted. This can be due to various factors, including regulatory hurdles, limited resources, and resistance to change within the medical community. As a result, some patients may not have access to the most advanced breast lesion localization methods, which could limit the market's growth. While breast lesion localization methods have improved significantly in recent years, they need to get improved in terms of accuracy. False positive and negative results can lead to unnecessary or delayed treatments, which are frustrating and stressful for patients. As a result, there is a need for continued research and development of breast lesion localization methods to improve their accuracy and reliability. These restraints highlight challenges facing the breast lesion localization methods market, including cost, safety concerns, limited availability and adoption of new technologies, accuracy issues, and patient fears and stigma. However, there are opportunities for the market to overcome these challenges and continue to grow through continued research and development, improved accessibility and affordability, and greater patient education and awareness. Opportunities: Growing demand for minimally invasive procedures: We can see a rising trend towards minimally invasive procedures in healthcare, and this is no exception in the field of breast lesion localization. The USA Department of Health and Human Services estimates that approximately 60% of all breast biopsies are performed using minimally invasive techniques now, such as ultrasound-guided or stereotactic. This presents an opportunity to develop and adopt less invasive breast lesion localization methods, such as vacuum-assisted biopsy, which can reduce patient discomfort and lead to faster recovery times. Advances in artificial intelligence and machine learning: Artificial intelligence and machine learning technologies can potentially improve the accuracy and efficiency of breast lesion localization methods. According to a survey report by the Healthcare Information and Management Systems Society (HIMSS), 56% of healthcare organizations currently use AI in some form, while an additional 25% plan to implement AI soon. These technologies can analyze large amounts of data and assist radiologists in identifying and localizing breast lesions, reducing the risk of false positives and negatives. Emerging markets: The breast lesion localization market is anticipated to grow significantly in emerging markets such as China, India, and Brazil. These countries have large populations and rising incidences of breast cancer and are investing in healthcare infrastructure and technologies to meet the growing demand for breast cancer screening and treatment. Adoption of digital breast tomosynthesis: Digital breast tomosynthesis is an emerging breast imaging technology that has shown promise in improving the accuracy of breast lesion localization methods. A study by the University of California found that nearly 44% of women with non-dense breasts have a low-to-average risk for breast cancer screening by digital breast tomosynthesis (DBT). This Technology creates 3D images of the breast, which can provide greater detail and help distinguish between benign and malignant lesions. Overall, these opportunities highlight some of the areas where the breast lesion localization methods market can continue to grow and innovate through the development and adoption of less invasive methods, the use of AI and ML technologies, the expansion into emerging markets, a focus on patient-centric care, and the adoption of emerging imaging technologies. Market Analysis Of Different Segments Covered in the Report By Type of Technique: Mammography-guided localization Ultrasound-guided localization Magnetic resonance imaging (MRI)-guided localization Others (including X-rays, CT scans, and nuclear medicine) By Type of Procedure: Biopsy Lumpectomy Mastectomy Others (including lymph node dissection and breast reconstruction) By Type of End User: Hospitals Diagnostic Imaging Centers Ambulatory Surgical Centers Others (including research institutions and academic medical centers) By Type of Product: Wire Localization Devices Radioactive Seed Localization Devices Magnetic Tracers Other Localization Devices By Type of Application: Diagnosis Treatment Regional Coverage Analysis North America US. Canada Mexico Europe Germany France Italy Switzerland UK. Rest of Europe Asia-Pacific Japan China India Rest of Asia-Pacific LAMEA Brazil Israel South Africa Saudi Arabia Rest of LAMEA By Type of Technique, Mammography-guided localization is the most common method, accounting for around 70% of breast lesion localizations, due to its relatively low cost and high accuracy. It involves X-ray imaging to locate the lesion within the breast tissue. It is typically used for small, early-stage lesions not visible on physical examination. Ultrasound-guided localization is also a common method accounting for around 20% of breast lesion localizations, particularly for lesions that are difficult to see using mammography alone. Magnetic resonance imaging (MRI)-guided localization is becoming increasingly popular due to its high sensitivity and ability to detect small lesions that may not be visible on other imaging modalities accounting for around 5% of breast lesion localizations. Other techniques, such as X-ray, CT scan, and nuclear medicine, account for less than 5% of breast lesion localizations. By Type of Procedure, Lumpectomy, which involves the removal of only the cancerous tissue and some surrounding healthy tissue, is the most common procedure, particularly for early-stage breast cancer. The American Society of Breast Surgeons says that up to 50% of breast cancer surgeries now involve breast-conserving or lumpectomy, which is minimally invasive. Biopsy is also a common procedure performed using breast lesion localization methods. It is generally used to confirm the presence of cancerous or pre-cancerous cells within a breast lesion. Mastectomy is the surgical removal of the whole breast and is typically used for larger or more advanced cancers and accounts for 30% of breast cancer surgeries. Other procedures, such as lymph node dissection and breast reconstruction, are less commonly performed. By Type of End User, Hospitals are the largest end-user, accounting for around 75% of all procedures, due to the high volume of breast cancer patients treated within these facilities. Diagnostic imaging centers are also significant end users, as they typically perform imaging procedures for locating breast lesions. Diagnostic imaging centers account for around 20% of all procedures. Ambulatory surgical centers are becoming increasingly popular for breast lesion localization procedures due to their lower cost and shorter recovery times. Other end users, such as research institutions and academic medical centers, are less commonly involved in breast lesion localization. Ambulatory surgical centers and other end users account for less than 5% of all procedures. By Type of Product, Wire localization devices are the most common product type, accounting for around 80% of all procedures, due to their low cost relatively and ease of use. Radioactive seed localization devices are becoming increasingly popular, particularly for smaller, more difficult-to-locate lesions, and this process accounts for around 15% of all procedures. Magnetic tracers are also gaining popularity due to their high sensitivity and ability to detect small lesions. Magnetic tracers account for less than 5% of all procedures. Other localization devices, such as those based on radiofrequency or electromagnetic fields, are less commonly used. By Type of Application, Breast lesion localization methods are primarily used for diagnosis, with the primary application accounting for around 85% of all procedures. They are typically used to confirm the presence of cancerous or pre-cancerous cells within a breast lesion. The secondary application is treatment, accounting for around 15% of all procedures. Treatment is also an important application, particularly for early-stage breast cancer, as it allows for the removal of cancerous tissue while preserving as much healthy tissue as possible. By Type of Region, North America is the largest market for breast lesion localization methods, accounting for around 45% of the global market share due to the high prevalence of breast cancer in this region and the high level of healthcare spending. Europe is also a significant market and accounts for around 35% of the global market share., particularly in countries such as France, Germany, and the United Kingdom. Asia Pacific accounts for around 15% of the global market share. Asia Pacific is expected to experience strong growth in the coming years due to increasing awareness of breast cancer and improving healthcare infrastructure in countries such as China and India. Middle East, Africa, and Latin America are smaller markets. Still, they are also expected to experience growth in the coming years and account for around 5% of the global market share. Breast Lesion Localization Methods Market Report Coverage Report Attributes Details Market Size Value in 2023 USD 1.14 billion Revenue Forecast in 2030 USD 2.32 billion Growth Rate (CAGR 2023-2030) 11.68% Base Year for Estimation 2022 Historical Data 2017-2021 Segmentation By Type of Technique, By Type of Procedure, By Type of End User, By Type of Product, By Type of Application, By Type of Region Based on the Type of Technique Mammography-guided localization, Ultrasound-guided localization, Magnetic resonance imaging (MRI)-guided localization, and Others (including X-ray, CT scan, and nuclear medicine) Based on the Type of Procedure Biopsy, Lumpectomy, Mastectomy, and Others (including lymph node dissection and breast reconstruction) Based on the Type of End User Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers, Others (including research institutions and academic medical centers) Based on the Type of Product Wire Localization Devices, Radioactive Seed Localization Devices, Magnetic Tracers, and Other Localization Devices Based on the Type of Application Diagnosis, Treatment Based on the type of Region North America, Asia Pacific, Europe, Latin America, the Middle East, and Africa Breast Lesion Localization Methods Market Competitive Landscape Analysis C.R. Bard, Inc. (a subsidiary of Becton, Dickinson, and Company) Cook Medical LLC STERYLAB S.r.l. Tsunami Medical S.r.l. Argon Medical Devices, Inc. CP Medical, Inc. Galini SRL INTRAMEDICAL IMAGING LLC SOMATEX Medical Technologies GmbH STI Laser Industries Ltd. These players compete on factors such as product quality, pricing, and innovation and may also engage in mergers and acquisitions to expand their market presence. In addition, collaborations and partnerships with other companies or research institutions are common strategies to drive growth and innovation in the market. The market is also characterized by several local and regional players, particularly in emerging markets. These players may focus on specific niches within the market or compete on price to gain market share. Frequently Asked Question About This Report How big is Breast Lesion Localization Methods Market? The value of the Market size of the Breast Lesion Localization Methods Market is USD 1.14 billion in 2023. What is the CAGR rate for the Breast Lesion Localization Methods Market over the forecasted period? The CAGR for the Breast lesion localization market is 11.68% Which is the leading end-user for Breast Lesion Localization Methods Market? Hospitals are the largest end-user of the Breast Lesion Localization Methods Market. Who are the leading companies in the Breast Lesion Localization Methods Market? The major competitors in the Breast Lesion Localization Methods Market include C.R. Bard, Inc. (Becton, Dickinson, and Company), Cook Medical LLC, Argon Medical Devices, Inc., Tsunami Medical, Sterylab, STERYLAB S.r.l., Biopsybell S.r.l., Hologic, Inc., SOMATEX Medical Technologies GmbH and Medtronic. Which Region has the most significant share of the Market of Breast Lesion Localization Methods? North America has the most significant share of the Breast Lesion Localization Methods market. Sources: https://www.cdc.gov/mmwr/volumes/73/wr/mm7315e1.htm https://pmc.ncbi.nlm.nih.gov/articles/PMC8822551/ https://seer.cancer.gov/statfacts/html/breast.html https://www.accenture.com/au-en/insights/health/artificial-intelligence-healthcare https://www.cms.gov/newsroom/press-releases/national-health-spending-grew-slightly-2021 https://www.himss.org/sites/hde/files/media/file/2024/03/01/2023-himss-cybersecurity-survey-x.pdf https://pmc.ncbi.nlm.nih.gov/articles/PMC9198754/ https://www.radiologyinfo.org/en/info/breastbius https://emedicine.medscape.com/article/1276001-overview Table of Contents 1. EXECUTIVE SUMMARY 1.1. Market Attractiveness 1.2. Understanding the Target Customers 1.3. CXO perspective 1.4. Global Breast Lesion Localization Market, Historical Market Size & Future Projections Analysis 1.5. Global Breast Lesion Localization Market, By Technique 1.6. Global Breast Lesion Localization Market, By Procedure 1.7. Global Breast Lesion Localization Market, By Product 1.8. Global Breast Lesion Localization Market, By Application 1.9. Global Breast Lesion Localization Market, By End-User 1.10. Global Breast Lesion Localization Market, By Region 2. MARKET SHARE ANALYSIS 2.1. Top 10 Players with Revenue and Sales Volume 2.2. Market Share, 2022 3. SALES VOLUME (UNITS), NUMBER OF PROCEDURES/NUMBER OF DEPLOYMENTS (UNITS), BY REGION 3.1. North America (United States, Canada) 3.2. Europe (UK, Germany, France, Netherlands, Italy, Spain, Benelux, Rest of Europe) 3.3. Asia Pacific (China, Japan, South Korea, India, Australia, Rest of APAC) 3.4. Latin America 3.5. Middle East and Africa 4. INVESTMENT OPPORTUNITIES IN THE MARKET 4.1. On Going Market Developments 4.2. Merger & Acquisition Trends 4.3. Key Investment Opportunities 4.4. Most Potential Technique Segments from Growth and Investment Perspective 5. MARKET INTRODUCTION 5.1. Definition 5.2. Scope of the Study 5.3. Market Structure 5.4. Macro Factor Indicator Analysis 5.5. Key findings 5.5.1. Top investment pockets 6. RESEARCH METHODOLOGY 6.1. Research Process 6.2. Primary Research 6.3. Secondary Research 6.4. Market Size Estimation 6.5. Forecast Model 7. MARKET DYNAMICS 7.1. Introduction 7.2. Drivers 7.3. Restraints 7.4. Opportunities 7.5. Challenges 7.6. Covid 19 Impact Analysis 8. GLOBAL BREAST LESION LOCALIZATION MARKET ANALYSIS BY SEGMENT (REGION LEVEL ANALYSIS) 8.1. Overview 8.2. Global Breast Lesion Localization Historical Market size ($MILLION), Sales Volume, (2017 – 2021) 8.3. Global Breast Lesion Localization Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2027) 8.4. Global Breast Lesion Localization Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2027), By Technique 8.4.1. Mammography-guided localization 8.4.2. Ultrasound-guided localization 8.4.3. Magnetic resonance imaging (MRI)-guided localization 8.4.4. Others (including X-rays, CT scans, and nuclear medicine) 8.5. Global Breast Lesion Localization Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2027), By Procedure 8.5.1. Biopsy 8.5.2. Lumpectomy 8.5.3. Mastectomy 8.5.4. Others (including lymph node dissection and breast reconstruction) 8.6. Global Breast Lesion Localization Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2027), By Product 8.6.1. Wire Localization Devices 8.6.2. Radioactive Seed Localization Devices 8.6.3. Magnetic Tracers 8.6.4. Other Localization Devices 8.7. Global Breast Lesion Localization Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2027), By Application 8.7.1. Diagnosis 8.7.2. Treatment 8.8. Global Breast Lesion Localization Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2027), By End-User 8.8.1. Hospitals 8.8.2. Diagnostic Imaging Centers 8.8.3. Ambulatory Surgical Centers 8.8.4. Others (including research institutions and academic medical centers) 8.9. Global Breast Lesion Localization Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2027), By Geography 8.9.1. North America 8.9.2. Asia Pacific 8.9.3. Europe 8.9.4. Latin America 8.9.5. Middle East and Africa 9. NORTH AMERICA BREAST LESION LOCALIZATION MARKET ANALYSIS 9.1. Overview 9.2. North America Breast Lesion Localization Historical Market size ($MILLION), Sales Volume, (2017 – 2021) 9.3. North America Breast Lesion Localization Market size ($MILLION), Sales Volume and Forecasts (2022 – 2027) 9.4. North America Breast Lesion Localization Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2027), By Technique 9.4.1. Mammography-guided localization 9.4.2. Ultrasound-guided localization 9.4.3. Magnetic resonance imaging (MRI)-guided localization 9.4.4. Others (including X-rays, CT scans, and nuclear medicine) 9.5. North America Breast Lesion Localization Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2027), By Procedure 9.5.1. Biopsy 9.5.2. Lumpectomy 9.5.3. Mastectomy 9.5.4. Others (including lymph node dissection and breast reconstruction) 9.6. North America Breast Lesion Localization Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2027), By Product 9.6.1. Wire Localization Devices 9.6.2. Radioactive Seed Localization Devices 9.6.3. Magnetic Tracers 9.6.4. Other Localization Devices 9.7. North America Breast Lesion Localization Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2027), By Application 9.7.1. Diagnosis 9.7.2. Treatment 9.8. North America Breast Lesion Localization Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2027), By End-User 9.8.1. Hospitals 9.8.2. Diagnostic Imaging Centers 9.8.3. Ambulatory Surgical Centers 9.8.4. Others (including research institutions and academic medical centers) 9.9. North America Breast Lesion Localization Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2027), By Geography 9.9.1. USA 9.9.1.1. California 9.9.1.2. Texas 9.9.1.3. Florida 9.9.1.4. Pennsylvania 9.9.1.5. Illinois 9.9.1.6. North Carolina 9.9.1.7. Rest of the U.S. 9.9.2. Canada 9.9.3. Rest of North America 10. EUROPE BREAST LESION LOCALIZATION MARKET ANALYSIS 10.1. Overview 10.2. Europe Breast Lesion Localization Historical Market size ($MILLION), Sales Volume, (2017 – 2021) 10.3. Europe Breast Lesion Localization Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2027) 10.4. Europe Breast Lesion Localization Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2027), By Technique 10.4.1. Mammography-guided localization 10.4.2. Ultrasound-guided localization 10.4.3. Magnetic resonance imaging (MRI)-guided localization 10.4.4. Others (including X-rays, CT scans, and nuclear medicine) 10.5. Europe Breast Lesion Localization Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2027), By Procedure 10.5.1. Biopsy 10.5.2. Lumpectomy 10.5.3. Mastectomy 10.5.4. Others (including lymph node dissection and breast reconstruction) 10.6. Europe Breast Lesion Localization Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2027), By Product 10.6.1. Wire Localization Devices 10.6.2. Radioactive Seed Localization Devices 10.6.3. Magnetic Tracers 10.6.4. Other Localization Devices 10.7. Europe Breast Lesion Localization Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2027), By Application 10.7.1. Diagnosis 10.7.2. Treatment 10.8. Europe Breast Lesion Localization Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2027), By End-User 10.8.1. Hospitals 10.8.2. Diagnostic Imaging Centers 10.8.3. Ambulatory Surgical Centers 10.8.4. Others (including research institutions and academic medical centers) 10.9. Europe Global Breast Lesion Localization Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2027), By Region 10.9.1. Germany 10.9.2. UK 10.9.3. France 10.9.4. Spain 10.9.5. Italy 10.9.6. Benelux 10.9.7. Rest of Europe 11. ASIA PACIFIC BREAST LESION LOCALIZATION MARKET ANALYSIS 11.1. Overview 11.2. Asia Pacific Breast Lesion Localization Historical Market size ($MILLION), Sales Volume, (2017 – 2021) 11.3. Asia Pacific Breast Lesion Localization Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2027) 11.4. Asia Pacific Breast Lesion Localization Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2027), By Technique 11.4.1. Mammography-guided localization 11.4.2. Ultrasound-guided localization 11.4.3. Magnetic resonance imaging (MRI)-guided localization 11.4.4. Others (including X-rays, CT scans, and nuclear medicine) 11.5. Asia Pacific Breast Lesion Localization Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2027), By Procedure 11.5.1. Biopsy 11.5.2. Lumpectomy 11.5.3. Mastectomy 11.5.4. Others (including lymph node dissection and breast reconstruction) 11.6. Asia Pacific Breast Lesion Localization Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2027), By Product 11.6.1. Wire Localization Devices 11.6.2. Radioactive Seed Localization Devices 11.6.3. Magnetic Tracers 11.6.4. Other Localization Devices 11.7. Asia Pacific Breast Lesion Localization Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2027), By Application 11.7.1. Diagnosis 11.7.2. Treatment 11.8. Asia Pacific Breast Lesion Localization Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2027), By End-User 11.8.1. Hospitals 11.8.2. Diagnostic Imaging Centers 11.8.3. Ambulatory Surgical Centers 11.8.4. Others (including research institutions and academic medical centers) 11.9. Asia Pacific Breast Lesion Localization Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2027), By Region 11.9.1. China 11.9.2. Japan 11.9.3. Korea 11.9.4. India 11.9.5. Australia 11.9.6. Rest of APAC 12. LATIN AMERICA BREAST LESION LOCALIZATION MARKET ANALYSIS 12.1. Overview 12.2. Latin America Breast Lesion Localization Market Historical Market size ($MILLION), Sales Volume, (2017 – 2021) 12.3. Latin America Breast Lesion Localization Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2027) 12.4. Latin America Breast Lesion Localization Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2027), By Technique 12.4.1. Mammography-guided localization 12.4.2. Ultrasound-guided localization 12.4.3. Magnetic resonance imaging (MRI)-guided localization 12.4.4. Others (including X-rays, CT scans, and nuclear medicine) 12.5. Latin America Breast Lesion Localization Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2027), By Procedure 12.5.1. Biopsy 12.5.2. Lumpectomy 12.5.3. Mastectomy 12.5.4. Others (including lymph node dissection and breast reconstruction) 12.6. Latin America Breast Lesion Localization Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2027), By Product 12.6.1. Wire Localization Devices 12.6.2. Radioactive Seed Localization Devices 12.6.3. Magnetic Tracers 12.6.4. Other Localization Devices 12.7. Latin America Breast Lesion Localization Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2027), By Application 12.7.1. Diagnosis 12.7.2. Treatment 12.8. Latin America Breast Lesion Localization Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2027), By End-User 12.8.1. Hospitals 12.8.2. Diagnostic Imaging Centers 12.8.3. Ambulatory Surgical Centers 12.8.4. Others (including research institutions and academic medical centers) 12.9. Latin America Breast Lesion Localization Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2027), By Region 12.9.1. Latin America 12.9.2. Middle East 12.9.3. Africa 13. MIDDLE EAST AND AFRICA BREAST LESION LOCALIZATION MARKET ANALYSIS 13.1. Overview 13.2. Middle East and Africa Breast Lesion Localization Market Historical Market size ($MILLION), Sales Volume, (2017 – 2021) 13.3. Middle East and Africa Breast Lesion Localization Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2027) 13.4. Middle East and Africa Breast Lesion Localization Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2027), By Technique 13.4.1. Mammography-guided localization 13.4.2. Ultrasound-guided localization 13.4.3. Magnetic resonance imaging (MRI)-guided localization 13.4.4. Others (including X-rays, CT scans, and nuclear medicine) 13.5. Middle East and Africa Breast Lesion Localization Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2027), By Procedure 13.5.1. Biopsy 13.5.2. Lumpectomy 13.5.3. Mastectomy 13.5.4. Others (including lymph node dissection and breast reconstruction) 13.6. Middle East and Africa Breast Lesion Localization Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2027), By Product 13.6.1. Wire Localization Devices 13.6.2. Radioactive Seed Localization Devices 13.6.3. Magnetic Tracers 13.6.4. Other Localization Devices 13.7. Middle East and Africa Breast Lesion Localization Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2027), By Application 13.7.1. Diagnosis 13.7.2. Treatment 13.8. Middle East and Africa Breast Lesion Localization Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2027), By End-User 13.8.1. Hospitals 13.8.2. Diagnostic Imaging Centers 13.8.3. Ambulatory Surgical Centers 13.8.4. Others (including research institutions and academic medical centers) 13.9. Middle East and Africa Breast Lesion Localization Market size ($MILLION), Sales Volume, and Forecasts (2022 – 2027), By Region 13.9.1. Latin America 13.9.2. Middle East 13.9.3. Africa 14. COMPANY PROFILES 14.1. C.R. BARD, INC. (A SUBSIDIARY OF BECTON, DICKINSON, AND COMPANY) 14.1.1. Company Overview 14.1.2. Company Snapshot 14.1.3. Operating business segments 14.1.4. Technique offered and Revenue from Breast Lesion Localization Business 14.1.5. Key business performances, strategies and developments 14.2. COOK MEDICAL LLC 14.2.1. Company Overview 14.2.2. Company Snapshot 14.2.3. Operating business segments 14.2.4. Technique offered and Revenue from Breast Lesion Localization Business 14.2.5. Key business performances, strategies and developments 14.3. STERYLAB S.R.L. 14.3.1. Company Overview 14.3.2. Company Snapshot 14.3.3. Operating business segments 14.3.4. Technique offered and Revenue from Breast Lesion Localization Business 14.3.5. Key business performances, strategies and developments 14.4. SOMATEX MEDICAL TECHNOLOGIES GMBH 14.4.1. Company Overview 14.4.2. Company Snapshot 14.4.3. Operating business segments 14.4.4. Technique offered and Revenue from Breast Lesion Localization Business 14.4.5. Key business performances, strategies and developments 14.5. TSUNAMI MEDICAL S.R.L. 14.5.1. Company Overview 14.5.2. Company Snapshot 14.5.3. Operating business segments 14.5.4. Technique offered and Revenue from Breast Lesion Localization Business 14.5.5. Key business performances, strategies and developments 14.6. ARGON MEDICAL DEVICES, INC. 14.6.1. Company Overview 14.6.2. Company Snapshot 14.6.3. Operating business segments 14.6.4. Technique offered and Revenue from Breast Lesion Localization Business 14.6.5. Key business performances, strategies and developments 14.7. CP MEDICAL, INC. 14.7.1. Company Overview 14.7.2. Company Snapshot 14.7.3. Operating business segments 14.7.4. Technique offered and Revenue from Breast Lesion Localization Business 14.7.5. Key business performances, strategies and developments 14.8. GALINI SRL 14.8.1. Company Overview 14.8.2. Company Snapshot 14.8.3. Operating business segments 14.8.4. Technique offered and Revenue from Breast Lesion Localization Business 14.8.5. Key business performances, strategies and developments 14.9. INTRAMEDICAL IMAGING LLC 14.9.1. Company Overview 14.9.2. Company Snapshot 14.9.3. Operating business segments 14.9.4. Technique offered and Revenue from Breast Lesion Localization Business 14.9.5. Key business performances, strategies and developments 14.10. STI LASER INDUSTRIES LTD. 14.10.1. Company Overview 14.10.2. Company Snapshot 14.10.3. Operating business segments 14.10.4. Technique offered and Revenue from Breast Lesion Localization Business 14.10.5. Key business performances, strategies and developments 14.11. Other Market Players LIST OF TABLES 1. TABLE: MARKET, BY TECHNIQUE, 2022-2027 (USD MILLION) 2. TABLE: MARKET FOR MAMMOGRAPHY-GUIDED LOCALIZATION, BY REGION, 2022-2027 (USD MILLION) 3. TABLE: MARKET FOR ULTRASOUND-GUIDED LOCALIZATION, BY REGION, 2022-2027 (USD MILLION) 4. TABLE: MARKET FOR MAGNETIC RESONANCE IMAGING (MRI)-GUIDED LOCALIZATION, BY REGION, 2022-2027 (USD MILLION) 5. TABLE: MARKET FOR OTHERS (INCLUDING X-RAYS, CT SCANS, AND NUCLEAR MEDICINE), BY REGION, 2022-2027 (USD MILLION) 6. TABLE: MARKET, BY PROCEDURE, 2022-2027 (USD MILLION) 7. TABLE: MARKET FOR BIOPSY, BY REGION, 2022-2027 (USD MILLION) 8. TABLE: MARKET FOR LUMPECTOMY, BY REGION, 2022-2027 (USD MILLION) 9. TABLE: MARKET FOR MASTECTOMY, BY REGION, 2022-2027 (USD MILLION) 10. TABLE: MARKET FOR OTHERS (INCLUDING LYMPH NODE DISSECTION AND BREAST RECONSTRUCTION), BY REGION, 2022-2027 (USD MILLION) 11. TABLE: MARKET, BY PRODUCT, 2022-2027 (USD MILLION) 12. TABLE: MARKET FOR WIRE LOCALIZATION DEVICES, BY REGION, 2022-2027 (USD MILLION) 13. TABLE: MARKET FOR RADIOACTIVE SEED LOCALIZATION DEVICES, BY REGION, 2022-2027 (USD MILLION) 14. TABLE: MARKET FOR MAGNETIC TRACERS, BY REGION, 2022-2027 (USD MILLION) 15. TABLE: MARKET FOR OTHER LOCALIZATION DEVICES, BY REGION, 2022-2027 (USD MILLION) 16. TABLE: MARKET, BY APPLICATION, 2022-2027 (USD MILLION) 17. TABLE: MARKET FOR DIAGNOSIS BY REGION, 2022-2027 (USD MILLION) 18. TABLE: MARKET FOR TREATMENT, BY REGION, 2022-2027 (USD MILLION) 19. TABLE: MARKET FOR GERIATRIC, BY REGION, 2022-2027 (USD MILLION) 20. TABLE: MARKET FOR PEDIATRIC BY REGION, 2022-2027 (USD MILLION) 21. TABLE: MARKET FOR ADULT, BY REGION, 2022-2027 (USD MILLION) 22. TABLE: MARKET, BY END-USER, 2022-2027 (USD MILLION) 23. TABLE: MARKET FOR HOSPITALS, BY REGION, 2022-2027 (USD MILLION) 24. TABLE: MARKET FOR DIAGNOSTIC IMAGING CENTERS BY REGION, 2022-2027 (USD MILLION) 25. TABLE: MARKET FOR AMBULATORY SURGICAL CENTERS BY REGION, 2022-2027 (USD MILLION) 26. TABLE: MARKET FOR OTHERS (INCLUDING RESEARCH INSTITUTIONS AND ACADEMIC MEDICAL CENTERS), BY REGION, 2022-2027 (USD MILLION) 27. TABLE: MARKET, BY REGION, 2022-2027 (USD MILLION) 28. TABLE: NORTH AMERICA MARKET, BY REGION, 2022-2027 (USD MILLION) 29. TABLE: NORTH AMERICA MARKET, BY TECHNIQUE, 2022-2027 (USD MILLION) 30. TABLE: NORTH AMERICA MARKET, BY PROCEDURE, 2022-2027 (USD MILLION) 31. TABLE: NORTH AMERICA MARKET, BY PRODUCT, 2022-2027 (USD MILLION) 32. TABLE: NORTH AMERICA MARKET, BY APPLICATION, 2022-2027 (USD MILLION) 33. TABLE: NORTH AMERICA MARKET, BY END-USER, 2022-2027 (USD MILLION) 34. TABLE: USA MARKET BY TECHNIQUE, 2022-2027 (USD MILLION) 35. TABLE: USA MARKET, BY PROCEDURE, 2022-2027 (USD MILLION) 36. TABLE: USA MARKET, BY PRODUCT, 2022-2027 (USD MILLION) 37. TABLE: USA MARKET, BY APPLICATION, 2022-2027 (USD MILLION) 38. TABLE: USA MARKET, BY END-USER, 2022-2027 (USD MILLION) 39. TABLE: CALIFORNIA MARKET, BY TECHNIQUE, 2022-2027 (USD MILLION) 40. TABLE: CALIFORNIA MARKET, BY PROCEDURE, 2022-2027 (USD MILLION) 41. TABLE: CALIFORNIA MARKET, BY PRODUCT, 2022-2027 (USD MILLION) 42. TABLE: CALIFORNIA MARKET, BY APPLICATION, 2022-2027 (USD MILLION) 43. TABLE: CALIFORNIA MARKET, BY END-USER, 2022-2027 (USD MILLION) 44. TABLE: TEXAS MARKET BY TECHNIQUE, 2022-2027 (USD MILLION) 45. TABLE: TEXAS MARKET, BY PROCEDURE, 2022-2027 (USD MILLION) 46. TABLE: TEXAS MARKET, BY PRODUCT, 2022-2027 (USD MILLION) 47. TABLE: TEXAS MARKET, BY APPLICATION, 2022-2027 (USD MILLION) 48. TABLE: TEXAS MARKET, BY END-USER, 2022-2027 (USD MILLION) 49. TABLE: FLORIDA MARKET BY TECHNIQUE, 2022-2027 (USD MILLION) 50. TABLE: FLORIDA MARKET, BY PROCEDURE, 2022-2027 (USD MILLION) 51. TABLE: FLORIDA MARKET, BY PRODUCT, 2022-2027 (USD MILLION) 52. TABLE: FLORIDA MARKET, BY APPLICATION, 2022-2027 (USD MILLION) 53. TABLE: FLORIDA MARKET, BY END-USER, 2022-2027 (USD MILLION) 54. TABLE: CANADA MARKET, BY TECHNIQUE, 2022-2027 (USD MILLION) 55. TABLE: CANADA MARKET, BY PROCEDURE, 2022-2027 (USD MILLION) 56. TABLE: CANADA MARKET, BY PRODUCT, 2022-2027 (USD MILLION) 57. TABLE: CANADA MARKET, BY APPLICATION, 2022-2027 (USD MILLION) 58. TABLE: CANADA MARKET, BY END-USER, 2022-2027 (USD MILLION) 59. TABLE: MEXICO MARKET, BY TECHNIQUE, 2022-2027 (USD MILLION) 60. TABLE: MEXICO MARKET, BY PROCEDURE, 2022-2027 (USD MILLION) 61. TABLE: MEXICO MARKET, BY PRODUCT, 2022-2027 (USD MILLION) 62. TABLE: MEXICO MARKET, BY APPLICATION, 2022-2027 (USD MILLION) 63. TABLE: MEXICO MARKET, BY END-USER, 2022-2027 (USD MILLION) 64. TABLE: REST OF NORTH AMERICA MARKET, BY TECHNIQUE, 2022-2027 (USD MILLION) 65. TABLE: REST OF NORTH AMERICA MARKET, BY PROCEDURE, 2022-2027 (USD MILLION) 66. TABLE: REST OF NORTH AMERICA MARKET, BY PRODUCT, 2022-2027 (USD MILLION) 67. TABLE: REST OF NORTH AMERICA MARKET, BY APPLICATION, 2022-2027 (USD MILLION) 68. TABLE: REST OF NORTH AMERICA MARKET, BY END-USER, 2022-2027 (USD MILLION) 69. TABLE: EUROPE MARKET, BY REGION, 2022-2027 (USD MILLION) 70. TABLE: EUROPE MARKET, BY TECHNIQUE, 2022-2027 (USD MILLION) 71. TABLE: EUROPE MARKET, BY PROCEDURE, 2022-2027 (USD MILLION) 72. TABLE: EUROPE MARKET, BY PRODUCT, 2022-2027 (USD MILLION) 73. TABLE: EUROPE MARKET, BY APPLICATION, 2022-2027 (USD MILLION) 74. TABLE: EUROPE MARKET, BY END-USER, 2022-2027 (USD MILLION) 75. TABLE: GERMANY MARKET, BY TECHNIQUE, 2022-2027 (USD MILLION) 76. TABLE: GERMANY MARKET, BY PROCEDURE, 2022-2027 (USD MILLION) 77. TABLE: GERMANY MARKET, BY PRODUCT, 2022-2027 (USD MILLION) 78. TABLE: GERMANY MARKET, BY APPLICATION, 2022-2027 (USD MILLION) 79. TABLE: GERMANY MARKET, BY END-USER, 2022-2027 (USD MILLION) 80. TABLE: FRANCE MARKET, BY TECHNIQUE, 2022-2027 (USD MILLION) 81. TABLE: FRANCE MARKET, BY PROCEDURE, 2022-2027 (USD MILLION) 82. TABLE: FRANCE MARKET, BY PRODUCT, 2022-2027 (USD MILLION) 83. TABLE: FRANCE MARKET, BY APPLICATION, 2022-2027 (USD MILLION) 84. TABLE: FRANCE MARKET, BY END-USER, 2022-2027 (USD MILLION) 85. TABLE: UK MARKET, BY TECHNIQUE, 2022-2027 (USD MILLION) 86. TABLE: UK MARKET, BY PROCEDURE, 2022-2027 (USD MILLION) 87. TABLE: UK MARKET, BY PRODUCT, 2022-2027 (USD MILLION) 88. TABLE: UK MARKET, BY APPLICATION, 2022-2027 (USD MILLION) 89. TABLE: UK MARKET, BY END-USER, 2022-2027 (USD MILLION) 90. TABLE: ITALY MARKET, BY TECHNIQUE, 2022-2027 (USD MILLION) 91. TABLE: ITALY MARKET, BY PROCEDURE, 2022-2027 (USD MILLION) 92. TABLE: ITALY MARKET, BY PRODUCT, 2022-2027 (USD MILLION) 93. TABLE: ITALY MARKET, BY APPLICATION, 2022-2027 (USD MILLION) 94. TABLE: ITALY MARKET, BY END-USER, 2022-2027 (USD MILLION) 95. TABLE: SPAIN MARKET, BY TECHNIQUE, 2022-2027 (USD MILLION) 96. TABLE: SPAIN MARKET, BY PROCEDURE, 2022-2027 (USD MILLION) 97. TABLE: SPAIN MARKET, BY PRODUCT, 2022-2027 (USD MILLION) 98. TABLE: SPAIN MARKET, BY APPLICATION, 2022-2027 (USD MILLION) 99. TABLE: SPAIN MARKET, BY END-USER, 2022-2027 (USD MILLION) 100. TABLE: REST OF EUROPE MARKET, BY TECHNIQUE, 2022-2027 (USD MILLION) 101. TABLE: REST OF EUROPE MARKET, BY PROCEDURE, 2022-2027 (USD MILLION) 102. TABLE: REST OF EUROPE MARKET, BY PRODUCT, 2022-2027 (USD MILLION) 103. TABLE: REST OF EUROPE MARKET, BY APPLICATION, 2022-2027 (USD MILLION) 104. TABLE: REST OF EUROPE MARKET, BY END-USER, 2022-2027 (USD MILLION) 105. TABLE: ASIA PACIFIC MARKET, BY TECHNIQUE, 2022-2027 (USD MILLION) 106. TABLE: ASIA PACIFIC MARKET, BY PROCEDURE, 2022-2027 (USD MILLION) 107. TABLE: ASIA PACIFIC MARKET, BY PRODUCT, 2022-2027 (USD MILLION) 108. TABLE: ASIA PACIFIC MARKET, BY APPLICATION, 2022-2027 (USD MILLION) 109. TABLE: ASIA PACIFIC MARKET, BY END-USER, 2022-2027 (USD MILLION) 110. TABLE: CHINA MARKET, BY TECHNIQUE, 2022-2027 (USD MILLION) 111. TABLE: CHINA MARKET, BY PROCEDURE, 2022-2027 (USD MILLION) 112. TABLE: CHINA MARKET, BY PRODUCT, 2022-2027 (USD MILLION) 113. TABLE: CHINA MARKET, BY APPLICATION, 2022-2027 (USD MILLION) 114. TABLE: CHINA MARKET, BY END-USER, 2022-2027 (USD MILLION) 115. TABLE: INDIA MARKET, BY TECHNIQUE, 2022-2027 (USD MILLION) 116. TABLE: INDIA MARKET, BY PROCEDURE, 2022-2027 (USD MILLION) 117. TABLE: INDIA MARKET, BY PRODUCT, 2022-2027 (USD MILLION) 118. TABLE: INDIA MARKET, BY APPLICATION, 2022-2027 (USD MILLION) 119. TABLE: INDIA MARKET, BY END-USER, 2022-2027 (USD MILLION) 120. TABLE: JAPAN MARKET, BY TECHNIQUE, 2022-2027 (USD MILLION) 121. TABLE: JAPAN MARKET, BY PROCEDURE, 2022-2027 (USD MILLION) 122. TABLE: JAPAN MARKET, BY PRODUCT, 2022-2027 (USD MILLION) 123. TABLE: JAPAN MARKET, BY APPLICATION, 2022-2027 (USD MILLION) 124. TABLE: JAPAN MARKET, BY END-USER, 2022-2027 (USD MILLION) 125. TABLE: KOREA MARKET, BY TECHNIQUE, 2022-2027 (USD MILLION) 126. TABLE: KOREA MARKET, BY PROCEDURE, 2022-2027 (USD MILLION) 127. TABLE: KOREA MARKET, BY PRODUCT, 2022-2027 (USD MILLION) 128. TABLE: KOREA MARKET, BY APPLICATION, 2022-2027 (USD MILLION) 129. TABLE: KOREA MARKET, BY END-USER, 2022-2027 (USD MILLION) 130. TABLE: AUSTRALIA MARKET, BY TECHNIQUE, 2022-2027 (USD MILLION) 131. TABLE: AUSTRALIA MARKET, BY PROCEDURE, 2022-2027 (USD MILLION) 132. TABLE: AUSTRALIA MARKET, BY PRODUCT, 2022-2027 (USD MILLION) 133. TABLE: AUSTRALIA MARKET, BY APPLICATION, 2022-2027 (USD MILLION) 134. TABLE: AUSTRALIA MARKET, BY END-USER, 2022-2027 (USD MILLION) 135. TABLE: REST OF ASIA PACIFIC MARKET, BY TECHNIQUE, 2022-2027 (USD MILLION) 136. TABLE: REST OF ASIA PACIFIC MARKET, BY PROCEDURE, 2022-2027 (USD MILLION) 137. TABLE: REST OF ASIA PACIFIC MARKET, BY PRODUCT, 2022-2027 (USD MILLION) 138. TABLE: REST OF ASIA PACIFIC MARKET, BY APPLICATION, 2022-2027 (USD MILLION) 139. TABLE: REST OF ASIA PACIFIC MARKET, BY END-USER, 2022-2027 (USD MILLION) 140. TABLE: LATIN AMERICA MARKET, BY TECHNIQUE, 2022-2027 (USD MILLION) 141. TABLE: LATIN AMERICA MARKET, BY PROCEDURE, 2022-2027 (USD MILLION) 142. TABLE: LATIN AMERICA MARKET, BY PRODUCT, 2022-2027 (USD MILLION) 143. TABLE: LATIN AMERICA MARKET, BY APPLICATION, 2022-2027 (USD MILLION) 144. TABLE: LATIN AMERICA MARKET, BY END-USER, 2022-2027 (USD MILLION) 145. TABLE: MIDDLE EAST AND AFRICA MARKET, BY TECHNIQUE, 2022-2027 (USD MILLION) 146. TABLE: MIDDLE EAST AND AFRICA MARKET, BY PROCEDURE, 2022-2027 (USD MILLION) 147. TABLE: MIDDLE EAST AND AFRICA MARKET, BY PRODUCT, 2022-2027 (USD MILLION) 148. TABLE: MIDDLE EAST AND AFRICA MARKET, BY APPLICATION, 2022-2027 (USD MILLION) 149. TABLE: MIDDLE EAST AND AFRICA MARKET, BY END-USER, 2022-2027 (USD MILLION) 150. TABLE: C.R. BARD, INC. (A SUBSIDIARY OF BECTON, DICKINSON, AND COMPANY). COMPANY SNAPSHOT 151. TABLE: C.R. BARD, INC. (A SUBSIDIARY OF BECTON, DICKINSON, AND COMPANY). OPERATING SEGMENTS 152. TABLE: COOK MEDICAL LLC: COMPANY SNAPSHOT 153. TABLE: COOK MEDICAL LLC: OPERATING SEGMENTS 154. TABLE: STERYLAB S.R.L.: COMPANY SNAPSHOT 155. TABLE: STERYLAB S.R.L.: OPERATING SEGMENTS 156. TABLE: SOMATEX MEDICAL TECHNOLOGIES GMBH: COMPANY SNAPSHOT 157. TABLE: SOMATEX MEDICAL TECHNOLOGIES GMBH: OPERATING SEGMENTS 158. TABLE: TSUNAMI MEDICAL S.R.L.: COMPANY SNAPSHOT 159. TABLE: TSUNAMI MEDICAL S.R.L.: OPERATING SEGMENTS 160. TABLE: ARGON MEDICAL DEVICES, INC.: COMPANY SNAPSHOT 161. TABLE: ARGON MEDICAL DEVICES, INC.: OPERATING SEGMENTS 162. TABLE: CP MEDICAL, INC.: COMPANY SNAPSHOT 163. TABLE: CP MEDICAL, INC.: OPERATING SEGMENTS 164. TABLE: GALINI SRL: COMPANY SNAPSHOT 165. TABLE: GALINI SRL: OPERATING SEGMENTS 166. TABLE: INTRAMEDICAL IMAGING LLC: COMPANY SNAPSHOT 167. TABLE: INTRAMEDICAL IMAGING LLC: OPERATING SEGMENTS 168. TABLE: STI LASER INDUSTRIES LTD.: COMPANY SNAPSHOT 169. TABLE: STI LASER INDUSTRIES LTD.: OPERATING SEGMENTS LIST OF FIGURES 1. Figure: Market: Research Methodology Steps 2. Figure: Research Design 3. Figure: Breakdown of Primaries: Market 4. Figure: Research Methodology: Hypothesis Building 5. Figure: Market: Technique and Service-Based Estimation 6. Figure: Top 10 Companies with Highest No. Of Patent in Last 9 Years 7. Figure: Growth Strategies Adopted By the Key Players 8. Figure: Top 10 Companies with Highest No. Of Patent in Last 9 Years 9. Figure: Growth Strategies Adopted By the Key Players 10. Figure: No. of Patents Granted Per Year, 2022–2027 11. Figure: Data Triangulation Methodology 12. Figure: Dominating Market Share, By Technique, 2022 vs. 2027 (USD MILLION) 13. Figure: Dominating Market Share, By Procedure, 2022 vs. 2027 (USD MILLION) 14. Figure: Dominating Market Share, By Product, 2022 vs. 2027 (USD MILLION) 15. Figure: Dominating Market Share, By Application, 2022 vs. 2027 (USD MILLION) 16. Figure: Dominating Market Share, By End-User, 2022 vs. 2027 (USD MILLION) 17. Figure: Geographical Snapshot of the Market 18. Figure: Mammography-guided localization to Witness Higher CAGR in the Market for Technique Segment during the Forecast Period. 19. Figure: North America Accounted for the Largest Share of the Market, By Regional Basis, in 2022 20. Figure: Market: Drivers, Restraints, Opportunities, and Challenges 21. Figure: North America: Market Snapshot 22. Figure: Asia Pacific: Market Snapshot 23. Figure: Europe: Market Snapshot 24. Figure: Latin America: Market Snapshot 25. Figure: Middle East and Africa: Market Snapshot 26. Figure: Vendor Dive: Evaluation Overview 27. Figure: Global Breast Lesion Localization: Competitive Benchmarking 28. Figure: C.R. Bard, Inc. (a subsidiary of Becton, Dickinson, and Company). Financial Overview (2022-2027) 29. Figure: Cook Medical LLC: Financial Overview (2022-2027) 30. Figure: STERYLAB S.r.l.: Financial Overview (2022-2027) 31. Figure: SOMATEX Medical Technologies GmbH: Financial Overview (2022-2027) 32. Figure: Tsunami Medical S.r.l.: Financial Overview (2022-2027) 33. Figure: Argon Medical Devices, Inc.: Financial Overview (2022-2027) 34. Figure: CP Medical, Inc.: Financial Overview (2022-2027) 35. Figure: Galini SRL: Financial Overview (2022-2027) 36. Figure: Intramedical Imaging LLC: Financial Overview (2022-2027) 37. Figure: STI Laser Industries Ltd.: Financial Overview (2022-2027)